基于贝叶斯推断估算药物不良反应的致病药物
本研究基于日本不良事件报告数据库构建贝叶斯模型,估算处方药为特定不良反应致病药物的可能性,并在山口大学医院的67份报告(共1387种药物,67种致病药和1320种合并用药)中验证,模型区分度达AUC 0.93(95%CI 0.88-0.97)。
要点
- 贝叶斯模型可辅助识别药物不良反应的致病药物,验证AUC为0.93。
- 模型基于日本不良事件报告数据库开发,适用于多种不良反应场景。
- 估算结果可作为临床判断致病药物的一条线索,缩短处理周转时间。
核心结论
- 贝叶斯估计模型能以可接受的准确度估算不良反应的致病药物,AUC为0.93(95%CI 0.88-0.97)。
研究设计与样本
- 基于日本不良事件报告数据库开发贝叶斯估计模型,并在山口大学医院67份不良反应报告(共1387种药物,含67种致病药和1320种合并用药)中进行验证。
主要发现
- 验证中模型估算致病药物的ROC曲线下面积为0.93(95%CI 0.88-0.97)。
临床怎么用
- 模型提供的估算结果可作为医疗从业者判断各种不良反应致病药物的一条线索。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The utility of big data in spontaneous adverse drug reactions (ADRs) reporting systems has improved the pharmacovigilance process. However, identifying culprit drugs in ADRs remains challenging, although it is one of the foremost steps to managing ADRs. Aiming to estimate the likelihood of prescribed drugs being culprit drugs for given ADRs, we devised a Bayesian estimation model based on the Japanese Adverse Drug Events Reports database. After developing the model, a validation study was conducted with 67 ADR reports with a gross of 1,387 drugs (67 culprit drugs and 1,320 concomitant drugs) prescribed and recorded at Yamaguchi University Hospital. As a result, the model estimated a culprit drug of ADRs with acceptable accuracy (area under the receiver operating characteristic curve 0.93 (95% confidence interval 0.88-0.97)). The estimation results provided by the model to healthcare practitioners can be used as one clue to determine the culprit drugs for various ADRs, which will improve the management of ADRs by shortening the treatment turnaround time and increasing the precision of diagnosis, leading to minimizing the adverse effects on patients.
引用
- Hamada K, Abe T, Kouda K, et al. Estimating Culprit Drugs for Adverse Drug Reactions Based on Bayesian Inference. Clin Pharmacol Ther. 2023. PMID: 36752635. doi:10.1002/cpt.2867
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。